Sector:
Biotech
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
About
We develop AI and wet-lab technologies that enable the rational design of developable, selective, and functional drugs against previously undruggable targets.
To maximize the patient impact of our platform, we collaborate with leading pharmaceutical companies, including AstraZeneca, Bristol Myers Squibb and Takeda, to expand their pipelines with high-quality drug candidates.
If successful we could double the number of disease-relevant drug targets the industry advances for drug development.
Since launching in 2021 we have raised $37 million with the backing of leading investors, including Radical Ventures, Khosla Ventures and Zetta Venture Partners.
Our technical team is based in Cambridge, Massachusetts and continues to recruit top machine learning and synthetic biology talent.
Team
